Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Marksans Pharma Ltd.
Swot
Marksans Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Marksans Pharma Ltd. has 10 Strengths, 6 Weaknesses, 6 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(10)
Weakness
(6)
Opportunity
(6)
Threats
(1)
Others
(3)
Benjamin Graham Value Screen
Consistent Highest Return Stocks over Five Years
Mid-range Performer (DVM)
PEG lower than Industry PEG
Companies with Low Debt
Increasing Revenue every Quarter for the past 4 Quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers
Companies with growing costs YoY for long term projects
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
RSI indicating price weakness
Stocks Underperforming their Industry Price Change in the Quarter
Companies with Upcoming Results
Mutual Funds Increased Shareholding in Past Month
Companies with improving valuation scores after share price falls
MFs increased their shareholding last quarter
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months
US FDA Warning Letter
Stocks with improving cash flow, with good durability
Big Changes up or down in FII holding
Decline in Net Profit with falling Profit Margin (QoQ)
